Condition
Inflammatory Skin Disease
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Unknown2
Not Yet Recruiting1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05104723Phase 1Enrolling By Invitation
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
NCT06448702Not ApplicableNot Yet Recruiting
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT04215458Not ApplicableUnknown
Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases
NCT04937101Not ApplicableUnknownPrimary
The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases
Showing all 4 trials